

FDA warns Fresenius over Utah plant violations, citing leaking dialysis bags and visual inspection failures. Read the full compliance update.
You can purchase shares of Fresenius Medical Care (NYSE:FMS) through any online brokerage.
Other companies in Fresenius Medical Care’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
Fresenius Medical Care has a consensus price target of $24.90.
The stock price for Fresenius Medical Care (NYSE: FMS) is $22.81 last updated October 26, 2026 at 12:25 PM EDT.
There are no upcoming dividends for Fresenius Medical Care.
Fresenius Medical Care does not have any upcoming earnings scheduled.
There is no upcoming split for Fresenius Medical Care.
Fresenius Medical Care is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis...